円
562.00
Sep 19
Business Description
RaQualia Pharma Inc
ISIN : JP3967150008
Description
Financial Strength
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.86 | |||||
Equity-to-Asset | 0.56 | |||||
Debt-to-Equity | 0.66 | |||||
Debt-to-EBITDA | -11.57 | |||||
Piotroski F-Score | 1/9 | |||||
Altman Z-Score | 2.1 | |||||
Beneish M-Score | -3.82 | |||||
WACC vs ROIC |
Growth Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 18.5 | |||||
3-Year EBITDA Growth Rate | 35.5 | |||||
3-Year EPS without NRI Growth Rate | 21.2 | |||||
3-Year FCF Growth Rate | -27 | |||||
3-Year Book Growth Rate | 13.9 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 28.78 |
Momentum Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 39.42 | |||||
9-Day RSI | 40.27 | |||||
14-Day RSI | 42.81 | |||||
6-1 Month Momentum % | -1.45 | |||||
12-1 Month Momentum % | -17.68 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 3.69 | |||||
Quick Ratio | 3.55 | |||||
Cash Ratio | 2.56 | |||||
Days Inventory | 106.12 | |||||
Days Sales Outstanding | 117.86 | |||||
Days Payable | 66.76 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -1.1 | |||||
Shareholder Yield % | -15.27 |
Profitability Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 84.78 | |||||
Operating Margin % | -20.37 | |||||
Net Margin % | -29.28 | |||||
FCF Margin % | -11.29 | |||||
ROE % | -11.03 | |||||
ROA % | -8.04 | |||||
ROIC % | -11.58 | |||||
3-Year ROIIC % | 22 | |||||
ROC (Joel Greenblatt) % | -39.42 | |||||
ROCE % | -7.66 | |||||
Years of Profitability over Past 10-Year | 3 |
GF Value Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Forward PE Ratio | 21.53 | |||||
PS Ratio | 5.28 | |||||
PB Ratio | 2.15 | |||||
Price-to-Tangible-Book | 7.52 | |||||
EV-to-EBIT | -21.66 | |||||
EV-to-EBITDA | -39.37 | |||||
EV-to-Revenue | 5.51 | |||||
EV-to-FCF | -49.43 | |||||
Price-to-Projected-FCF | 5.25 | |||||
Price-to-Median-PS-Value | 0.35 | |||||
Price-to-Net-Current-Asset-Value | 75.64 | |||||
Earnings Yield (Greenblatt) % | -4.62 | |||||
FCF Yield % | -2.14 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
RaQualia Pharma Inc Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil 円) | 2,298.166 | ||
EPS (TTM) (円) | -31.13 | ||
Beta | 0.75 | ||
Volatility % | 29.55 | ||
14-Day RSI | 42.81 | ||
14-Day ATR (円) | 25.002567 | ||
20-Day SMA (円) | 593.25 | ||
12-1 Month Momentum % | -17.68 | ||
52-Week Range (円) | 479 - 943 | ||
Shares Outstanding (Mil) | 21.64 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 1 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
RaQualia Pharma Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
RaQualia Pharma Inc Stock Events
Event | Date | Price(円) | ||
---|---|---|---|---|
No Event Data |
RaQualia Pharma Inc Frequently Asked Questions
What is RaQualia Pharma Inc(TSE:4579)'s stock price today?
When is next earnings date of RaQualia Pharma Inc(TSE:4579)?
Does RaQualia Pharma Inc(TSE:4579) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |